The medical device giant just opened its wallet for a stake in a privately held company with a groundbreaking product.
The deal gives Boston Scientific a 34% stake in MiRus and an option to buy its TAVR business for an additional $3 billion ...
Boston Scientific may acquire full ownership of MiRus’ TAVR business for an additional $3bn after achieving certain ...
The deal gives Boston Scientific an approximately 34% ownership stake in Georgia-based MiRus, along with an exclusive option to fully acquire the company’s replacement aortic heart valve business for ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Just a year after Boston ...
The deal gives Boston Scientific a 34% equity stake in MiRus and an option to acquire its TAVR platform by making additional payments totaling $3 billion.
MARLBOROUGH, Mass., Aug. 27, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has obtained CE mark for the ACURATE Prime™ Aortic Valve System, the newest transcatheter ...
Boston Scientific (NYSE:BSX) announced today that it invested $1.5 billion in transcatheter aortic valve replacement (TAVR) ...